Form 4 for CBT CABOT CORP
Accepted 2023-11-14 00:00:00 ET · period of report 2023-11-10 · accession 0000950170-23-063827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-14 | 2023-11-10 | CBT | Kalkstein Hobart | EVP | S - Sale+OE | $73.91 | -50.7K | 68.4K | -43% | -$3.75M |
| DM | 2023-11-14 | 2023-11-10 | CBT | Kalkstein Hobart | EVP | M - OptEx | $50.12 | +50.7K | 94.6K | +115% | +$2.54M |
| D | 2023-11-14 | 2023-11-13 | CBT | Kalkstein Hobart | EVP | F - Tax | $74.08 | -3,187 | 69.6K | -4% | -$236.1K |
| D | 2023-11-14 | 2023-11-10 | CBT | Kalkstein Hobart | EVP | A - Grant | $0.00 | +4,435 | 72.8K | +6% | $0 |
| D | 2023-11-14 | 2023-11-10 | CBT | Kalkstein Hobart | EVP | A - Grant | $0.00 | +14.0K | 14.0K | New | $0 |
| DM | 2023-11-14 | 2023-11-10 | CBT | Kalkstein Hobart | EVP | M - OptEx | $0.00 | -50.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-10 | S | D | 26,217 | $73.94 | 68,383 | D | — | — | (F2) The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.800 to $74.130, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-11-10 | M | A | 24,475 | $50.00 | 92,858 | D | — | — | |
| 3 | Common | Common Stock | 2023-11-10 | M | A | 26,217 | $50.23 | 94,600 | D | — | — | |
| 4 | Common | Common Stock | 2023-11-10 | S | D | 24,475 | $73.87 | 68,383 | D | — | — | (F1) The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.805 to $73.935, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2023-11-13 | F | D | 3,187 | $74.08 | 69,631 | D | — | — | |
| 6 | Common | Common Stock | 2023-11-10 | A | A | 4,435 | $0.00 | 72,818 | D | — | — | |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-10 | A | A | 14,040 | $0.00 | 14,040 | D | $74.40 · — to 2033-11-09 | 14,040 Common Stock | (F3) The option vests over a three year period as follows: 30% on November 10, 2024, 30% on November 10, 2025 and 40% on November 10, 2026. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-10 | M | D | 24,475 | $0.00 | 0 | D | $50.00 · — to 2028-11-08 | 24,475 Common Stock | (F4) 24,475 shares were subject to the option. The option vested over a three year period as follows: 30% on November 9, 2019, 30% on November 9, 2020 and 40% on November 9, 2021. |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-10 | M | D | 26,217 | $0.00 | 0 | D | $50.23 · — to 2029-11-07 | 26,217 Common Stock | (F5) 26,217 shares were subject to the option. The option vested over a three year period as follows: 30% on November 8, 2020, 30% on November 8, 2021 and 40% on November 8, 2022. |